Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
Inflammatory Diseases
Tag: Inflammatory Diseases
Biotechnology
Questionable Data Jeopardizes Alzheimer’s Amyloid Theory
BioChannel
-
August 5, 2022
Biotechnology
Novel Alzheimer’s Therapy without Inflammatory Side Effects
BioChannel
-
August 5, 2022
Biotechnology
StockWatch: Alnylam Basks in the Glow of Heart Drug’s Phase III...
BioChannel
-
August 4, 2022
Biotechnology
Specific ATP Type Critical to Inflammatory Spread in Rheumatoid Arthritis
BioChannel
-
May 18, 2022
Biotechnology
StockWatch: Investors Unfazed by Biogen CEO Search, Aduhelm Cutbacks
BioChannel
-
May 6, 2022
Biotechnology
StockWatch: ALS Setback Hammers Amylyx, Longeveron Doubles on Positive Alzheimer’s Data
BioChannel
-
April 1, 2022
Biotechnology
Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis
BioChannel
-
January 31, 2022
Biotechnology
Jurassic Ambitions: TRexBio Targets Tregs with Janssen Collaboration
BioChannel
-
January 10, 2022
Biotechnology
Pancreatitis Trigger Identified in Calcium Channel
BioChannel
-
May 14, 2020
Biotechnology
Link Discovered between Blood Vessel Inflammation and Malfunctioning Mitochondria
BioChannel
-
May 11, 2020
1
2
Page 1 of 2
Recent posts
NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients with resectable non-small...
BioChannel
-
August 8, 2022
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
BioChannel
-
August 8, 2022
Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats
BioChannel
-
August 8, 2022
Random article
NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients...
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats
Lithuanian biotech group develops closer ties with Korea’s biotech industry –...
